Unveiling the geroprotective potential of Monarda didyma L.: insights from in vitro studies and a randomized clinical trial on slowing biological aging and improving quality of life.
Saved in:
| Title: | Unveiling the geroprotective potential of Monarda didyma L.: insights from in vitro studies and a randomized clinical trial on slowing biological aging and improving quality of life. |
|---|---|
| Authors: | Campisi M; Department of Cardiac, Thoracic, and Vascular Sciences and Public Health, University of Padua, Padua, Italy., Cannella L; Department of Cardiac, Thoracic, and Vascular Sciences and Public Health, University of Padua, Padua, Italy., Paccagnella O; Department of Statistical Sciences, University of Padua, Padua, Italy., Brazzale AR; Department of Statistical Sciences, University of Padua, Padua, Italy., Agnolin A; Department of Statistical Sciences, University of Padua, Padua, Italy., Grothe T; Mibelle Group Biochemistry, Bolimattstrasse 1, Buchs, 5033, Switzerland., Baumann J; Mibelle Group Biochemistry, Bolimattstrasse 1, Buchs, 5033, Switzerland., Pavanello S; Department of Cardiac, Thoracic, and Vascular Sciences and Public Health, University of Padua, Padua, Italy. sofia.pavanello@unipd.it.; Occupational Medicine Unit, University Hospital of Padua, Padua, Italy. sofia.pavanello@unipd.it.; Centre of Studies and Activities for Space, CISAS 'G. Colombo' of University of Padua, Padua, Italy. sofia.pavanello@unipd.it. |
| Source: | GeroScience [Geroscience] 2025 Jun; Vol. 47 (3), pp. 4253-4290. Date of Electronic Publication: 2025 Mar 10. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101686284 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2509-2723 (Electronic) Linking ISSN: 25092723 NLM ISO Abbreviation: Geroscience Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
